Jozef Stefan Institute Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2020
NCT04579770
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Jozef Stefan Institute

Active Ingredients

Drugs in Other Trials (3)

caffeine (1 trial)

ketone monoester (2 trials)

sodium bicarbonate (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 3
  • # of Trial APIs: 3